Background--Endothelial dysfunction is a key component of vascular vulnerability. Reactive hyperemia index (RHI), as assessed by the peripheral arterial tonometry, can noninvasively evaluate endothelial function. This study was designed to determine the additional prognostic value of endothelial function to the Synergy Between PCI With Taxus and Cardiac Surgery Score (SYNTAXsc) and the Framingham Risk Score (FRS) in predicting cardiovascular events in high-risk patients.
A n integrated approach for identifying patients who are at a high risk for near-future cardiovascular events is desirable for developing proper therapeutic strategies in cardiovascular medicine. 1 Cardiovascular risk assessment using established risk factors such as the Framingham Risk Score (FRS) does not exhaustively predict cardiovascular disease development. Endothelial dysfunction is associated with atherosclerotic progression and can often predict future cardiovascular events. [2] [3] [4] [5] [6] Coronary plaques and morphological findings using coronary angiography (CAG) reportedly improve cardiovascular event prediction. Synergy Between PCI With Taxus and Cardiac Surgery Score (SYNTAXsc) is an angiographic scoring system used to evaluate coronary atherosclerosis and anatomy complexity. 7 The SYNTAXsc is reportedly an effective tool for predicting a major cardiovascular event risk in stable patients with multivessel or left main coronary artery disease (CAD) and in patients with acute coronary syndromes, 8, 9 but not in stable patients with high-risk condition.
Reactive hyperemia-peripheral arterial tonometry (RH-PAT), which is used to measure the digital hyperemic response, is a noninvasive, automatic, and less operator-dependent test that is clinically used to evaluate endothelial function. 10, 11 Recently, we reported that the RH-PAT index (RHI) was useful for identifying female patients who were at high-risk for ischemic heart disease, 12 and Rubinshtein et al reported that the RHI predicted adverse cardiovascular events in patients without known CAD. 13 We hypothesized that adding RHI as an assessment of physiological endothelial function to the coronary complexity morphological assessment and classical risk score would provide substantial cardiovascular event prognostic information in high-risk patients, including stable patients with established CAD. based on the modified American Heart Association coronary tree segment classification and separately scored regarding bifurcations or trifurcations or aortic ostial localization, chronic occlusion, vessel tortuosity, length, calcification, and thrombus formation. Finally, each lesion score was added to obtain the patient's raw SYNTAXsc. Angiographers who calculated SYNTAXsc were blinded to clinical data and RH-PAT data, and patients with occluded infarct-related arteries were scored as occlusions of unknown duration. A high SYNTAXsc is indicative of complex coronary disease. 7 We assessed reproducibility of the SYNTAXsc in a random sample of 30 patients. The kappa values for SYNTAXsc (tertile partitioning) intra-and interobserver agreement were 0.80 and 0.69, respectively. 
RH-PAT Examination
The RH-PAT studies in all of the patients were uniformly performed early in the morning in the fasted state before medication intake and prior to CAG, but within 7 days of CAG. The PAT method has been previously described.
14 RH-PAT measurements were analyzed with a computerized, automated algorithm to reduce intra-and interobserver variability (Endo-PAT2000 software, version 3.0.4, Itamar Medical Ltd). The RH-PAT ratio was calculated using the ratio of the average PAT signal amplitude over a 1-minute time interval, starting 1.5 minutes after cuff deflation (where control arm=A and the occluded arm=C), divided by the average PAT signal amplitude 2.5 minutes before cuff inflation (baseline) (where the control arm=B and the occluded arm=D), and the RH-PAT ratio=(C/D)/(A/B) ( Figure 1A 13, 15 Ln_RH-PAT ratio and baseline pulse amplitude were retrospectively analyzed using Endo-PAT2000 software (version 3.4.4); however, reanalysis was impossible in 2 patients for unknown reasons. Peripheral endothelial function as assessed by the RHI was validated by coronary artery response to acetylcholine, which is the gold standard coronary endothelial functional measurement. 12, 16 Previous studies demonstrated that RH-PAT technology has excellent reproducibility. for dyslipidemia) and, diabetes mellitus (diabetes symptoms and casual plasma glucose concentration ≥200 mg/dL, fasting plasma glucose concentration ≥126 mg/dL, 2-hour plasma glucose concentration ≥200 mg/dL during 75 g oral glucose tolerance test or hypoglycemic medication), and the presence of a family history of CAD.
Blood Tests and Risk Assessment by Framingham Risk Score (FRS)
Venous blood samples were obtained early in the morning after a 12-hour fast on the day after admission to measure fasting blood glucose, hemoglobin A1c, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, insulin, creatinine, B-type natriuretic peptide (BNP), and high-sensitivity C-reactive protein (hsCRP) levels. Estimated glomerular filtration rates (eGFRs) were determined using the prediction equation proposed by the Japanese Society of Nephrology and based on the equation described in the Modification of Diet in Renal Disease Study. 20 D'Agostino et al reported the FRS for primary and secondary prevention of the composite cardiovascular events. 21 In their study, cardiovascular events occurred in 24.7% of patients with coronary heart disease or stroke during 4-year follow-up period. We adopted this risk model in our study, and stratified study patients into 1 of 3 risk categories 
Follow-up and Cardiovascular Events
After optimal therapies including coronary revascularization, patients were followed until August 2012. Cardiovascular events consisted of cardiovascular death, nonfatal myocardial infarction, unstable angina, ischemic stroke, coronary revascularization, heart failure-induced hospitalization, nonfatal aortic disease, and peripheral arterial disease. Cardiovascular events were documented by phone calls to patients or their families and direct consultation with their physicians. In order to verify diagnosis of the cardiovascular events, 3 independent physicians comprising events committee reviewed all medical records (electrocardiograms, ultrasound echocardiograms, cardiac enzyme data, radiographic images, and death certificates) and validated cardiovascular events. If the reviewing physicians disagreed on the event classification, they adjudicated differences. Cardiovascular death was defined as death because of myocardial infarction (within 28 days), congestive heart failure, or documented sudden death without apparent noncardiovascular causes. Myocardial infarction was diagnosed by a rise or fall in cardiac biomarkers (plasma creatine kinase-MB or cardiac troponin) above the 99th percentile of the normal range upper limit together with evidence of myocardial ischemia and at least 1 of the following symptoms: electrocardiogram changes (new ST-T changes, left bundle branch block, or pathological Q wave) or imaging evidence of new viable myocardium loss, or a new regional wall motion abnormality. A diagnosis of unstable angina pectoris was made by new or accelerating myocardial ischemia symptoms accompanied by new ischemic ST-T-wave changes. Ischemic stroke diagnosis was based on the documented focal neurologic deficit with radiological evidence of brain infarction excluding intracranial hemorrhage. Hospitalization for heart failure decompensation was made if the patient was admitted with typical heart failure symptoms and had objective signs of worsening heart failure that required intravenous drug administration. A diagnosis of aortic and peripheral arterial disease was based on radiological imaging evidence and surgery requirement or percutaneous intervention.
Statistical Analysis
The continuous variable distributions were tested for normality using the Kolmogorov-Smirnov test. Continuous variable data with normal distribution were expressed as the mean (standard deviation), and the data with skewed distributions were expressed as medians [interquartile range]. Differences between normally distributed continuous variables were analyzed by an unpaired t test or one-way analysis of variance (ANOVA) with the post-hoc Bonferroni test. We used the Mann-Whitney U test for continuous variables with a skewed distribution. We compared groups using the chi-squared test. We calculated the cumulative cardiovascular event incidence with the Kaplan-Meier method and compared cardiovascular event incidence with the log-rank test. We used the median value RHI of 0.531 to divide patients into 2 groups (high and low RHI). To account for the confounding variables, propensity score was calculated in each patient using a logistic regression model in which the dependent variable was high RHI (>median), high Ln_RH-PAT ratio (>median), or high baseline pulse amplitude (>median), respectively. Independent variables included in the propensity score model were age, gender, body mass index, hypertension, diabetes, current smoking, family history of CAD, systolic blood pressure, diastolic blood pressure, hemoglobin A1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, left ventricular ejection fraction, BNP, hsCRP, eGFR, treatment with aspirin, hydroxymethylglutaryl-CoA reductase inhibitors, calcium We confirmed the proportional hazards assumption using Schoenfeld's test. Estimates of C-statistics for the Cox proportional hazards regression models were calculated. 22 The C-statistics were compared after the addition of BNP levels, the SYNTAXsc, and the RHI to the FRS. 21 We also examined whether various combinations of these parameters improved the model's discriminatory power. We performed likelihood ratio tests to evaluate whether the global model fit improved after RHI addition. We also evaluated whether adding the RHI to the FRS, BNP levels, and SYNTAXscs had an incremental effect in predicting cardiovascular events using the net reclassification index. 23 To assess reclassification improvement, we defined 3 risk categories on the basis of the FRS (primary and secondary prevention for 2-year risk for cardiovascular events) 21 : lowintermediate risk; <12%, high risk; 12% to 25%, or very high risk; >25%.
When we performed power analysis, we used the past report from Japan. 24 When we fixed parameters as follows, the estimated required patient number was 463: event-free rate 85%, hazard ratio 2.1, power 0.9, and alpha error 0.05. The number that we enrolled in the present study (n=528) was appropriate when compared with the number that was estimated by the power analysis (n=463). Statistical significance was defined as P<0.05 and all of the tests were 2 tailed. All analyses were performed using PASW 18 for Windows (SPSS Inc), STATA version 11.2 (StataCorp LP), and the SAS 9.2 program for Windows (SAS Institute Inc). The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written. Figure 2 shows the study flow chart. At baseline, we initially included 577 stable, high-risk patients with suspected CAD without heart failure. We excluded a total of 49 patients from the analysis on the basis of advanced endocrine disease (n=6), hepatic disease (n=9), renal disease (n=11), active inflammatory disease (n=8), cancer (n=7), and cerebrovascular disease with residual hemiplegia (n=8). The study did not include patients with acute coronary syndromes. After the baseline evaluation that included the RHI, CAG was performed in all of the patients. Four hundred and forty-two patients had ≥50% coronary artery diameter narrowing and were diagnosed as having stable CAD. Depending on their coronary anatomy, patients with CAD were then treated with percutaneous coronary intervention (PCI) (n=344, 77.8%), coronary artery bypass graft surgery (n=21, 4.8%), or medical therapy alone (n=77, 17.4%). In patients undergoing PCI, a bare metal stent (n=64, 18.6%) or a drug-eluting stent (n=269, 78.2%) was used per operator discretion. At discharge, 98.4%, 93.4%, 63.6%, and 75.1% of the CAD patients were taking aspirin, hydroxymethylglutaryl-CoA reductase inhibitors, b-blockers, and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for achieving the optimal medical therapy, respectively.
Results

Patient Enrollment
Baseline Clinical Characteristics
Study patient baseline characteristics are shown in Tables 1  through 4 . The mean patient age was 67.2AE10.7 years, and coronary risk factor prevalence for hypertension, diabetes, dyslipidemia, current smoking, and family histories of CAD was 81.3%, 47.0%, 83.0%, 21.2%, and 24.6%, respectively. Representative records of RH-PAT signals in patients with or without cardiovascular events are shown in Figure 1B and 1C. 
Cardiovascular Events
During a mean follow-up period of 2.8 years with a 1.7-year SD, which corresponds to 1468 person-years, 105 patients developed cardiovascular events. Those patients who developed cardiovascular events during the follow-up period were significantly older and had a lower body mass index, higher BNP levels, higher hsCRP levels, reduced eGFR, increased CAD prevalence, higher FRS, higher SYNTAXsc, and a lower RHI than patients without cardiovascular events (Table 2 and Figure 3A) . Table 5 ). Specifically, acute coronary syndrome, ischemic stroke, coronary revascularization, and heart failure were significantly higher in the low-RHI group than in the high-RHI group (Table 5) .
Cox Proportional Hazard Analysis for Cardiovascular Events
The multivariate analysis with backward algorithms revealed that age, BNP levels, SYNTAXsc, and RHI were independent predictors of cardiovascular events (age HR per 1 year was 1.024 with a 95% CI of 1.000 to 1. (RHI; per 0.1, HR 0.742, 95% CI; 0.643 to 0.856, P<0.0001). Kaplan-Meier analysis based on high and low RHI values demonstrated that there was a significantly higher cardiovascular event probability in the low RHI group during the followup period (log-rank test P<0.0001) ( Figure 3B ). Kaplan-Meier estimates for patients in each category by BNP levels and SYNTAXsc confirmed that low RHI values significantly improved cardiovascular events prediction ( Figure 4A and 4B).
Net Reclassification Index and C-statistics for Cox Proportional Hazard Models to Predict Cardiovascular Events
We treated BNP levels, SYNTAXsc, and RHI values as continuous and reclassified risk scores for the study patients. Significance was achieved in the resultant net reclassification index by adding RHI to the FRS alone (net reclassification index 48.9%; P<0.0001) or to FRS+BNP+SYNTAXsc (net reclassification index 27.5%; P<0.0001) ( Table 7) .
We estimated the C-statistic of the FRS alone. Individual BNP level, SYNTAXsc, and RHI value incorporation into the FRS increased the C-statistic for cardiovascular event prediction. Adding RHI values to the FRS, BNP level, and SYNTAXsc produced a significant increase in the C-statistic, from 0.728 to 0.766 (P=0.031, Table 8 ). We confirmed appropriate proportional hazards assumptions using Schoenfeld's test (P=0.476). RHI addition to the model with FRS, BNP levels, and SYNTAXsc demonstrated a better global fit compared with the model without RHI, as evaluated by the likelihood ratio test (P=0.017). We examined the interaction among all of the variables for effect modification and found that only SYNTAXsc had an interaction with RHI (P=0.005).
We conducted an analysis of a prespecified subgroup of established CAD patients (n=442). CAD patients with cardiovascular events had significantly lower RHI values than those without cardiovascular events ( Figure 5A ). Kaplan-Meier estimates for CAD patients in each category by RHI values, BNP levels, and SYNTAXsc revealed that the low RHI values significantly improved cardiovascular event prediction (Figures 5B, 6A , and 6B). Among CAD patients, the net reclassification index and C-statistics were also significantly improved by adding RHI to the FRS, BNP levels, and SYNTAXsc (net reclassification index was 29.2%; P<0.0001; C-statistic changed from 0.694 to 0.735; P=0.046) (Tables 8 and 9 ).
Ln_RH-PAT Ratio and Baseline Pulse Amplitude
We also evaluated the prognostic value of baseline pulse amplitude and Ln_RH-PAT ratio, which is uncorrected for baseline pulse amplitude. The relation of baseline pulse amplitude and Ln_RH-PAT ratio with cardiovascular risk factors are shown in Table 10 . Cox proportional hazard analysis revealed that Ln_RH-PAT ratio was significantly associated with cardiovascular events in the single model and the model with propensity score adjustment (single analysis, the Ln_RH-PAT ratio HR per 0.1 was 0.796 with a 95% CI of 0.727 to 0.873; P<0.0001) (the model with propensity score adjustment, the Ln_RH-PAT ratio HR per 0.1 was 0.816 with a 95% CI of 0.740 to 0.899; P<0.0001). Baseline pulse amplitude did not have significant relation to cardiovascular events in the single and the adjustment model (single analysis, the baseline pulse amplitude HR per 1 was 1.000 with a 95% CI of 0.999 to 1.000; P=0.349) (the model with propensity score adjustment, the baseline pulse amplitude HR per 1 was 1.000 with a 95% CI of 0.999 to 1.000; P=0.233). The addition of Ln_RH-PAT ratio to the FRS, BNP levels, and SYNTAXsc increased the C-statistics (Table 11) , and the net reclassification indices were significant with the inclusion of Ln_RH-PAT ratio in the whole study population and in CAD patients (Tables 12 and 13 ).
Discussion
Among patients who were high risk for a cardiovascular event, RHI values successfully and incrementally predicted future cardiovascular events. We demonstrated that adding the RHI value to the Framingham risk model, SYNTAXsc anatomical assessment, and BNP levels improved risk classification, as evidenced by a net reclassification index and a significant increase in the C-statistics. These findings indicated that an additional physiological assessment of endothelial function could be clinically valuable to identify vulnerable patients who may develop near-future cardiovascular events. Atherosclerotic lesions with a high probability of acute thrombotic complications because of plaque rupture or superficial endothelial erosion should be considered "vulnerable plaques." Currently, cardiovascular risk stratification with established coronary risk factors cannot fully predict the development of acute cardiovascular complications, especially the near-future cardiovascular events. 1, 25 The cardiovascular events frequently occurred in the highest-risk population with history of CAD and those with the established evidence of athero-thrombotic diseases. Thus, these populations should be the most clinically important patients to prevent the occurrence of cardiovascular events, however the practical risk stratification strategy for these patients has not been proposed. 1 Most plaque disruption occurs in moderately stenotic plaques that contain a soft, lipid-rich core covered by a thin, inflamed fibrous cap, which often accompanies endothelial dysfunction. 26 Severe endothelial dysfunction predisposes an individual to vulnerable endothelium, which could lead to plaque disruption and thrombosis.
In the present study, we showed that using the RHI value in conjunction with the FRS improved future cardiovascular event prediction. Based on these findings, we propose an additional physiological biomarker assessing endothelial dysfunction, which could be an integrated measurement of all atherogenic and atheroprotective factors. A combined approach with an FRS-based risk classification, noninvasive physiological RHI, anatomical coronary plaque complexity, and BNP levels might be clinically valuable and could be an integrative strategy for cardiovascular risk assessment in high-risk patients. Complementing unknown risk conditions assessed by RH-PAT would open a new era of patient risk stratification in cardiovascular medicine. Although endothelial function testing is expectantly desired in clinical practice, endothelial function as determined by brachial artery flow-dependent vasodilation (FMD) has not been successfully incorporated into the current integrative risk stratification system because of its operator dependency and technical problems. 18, 27 The additional benefits of FMD to traditional risk factors in the cardiovascular risk reclassification have not been established. 4, 6 Practically with clinical utility, digital RHI is a reproducible and less operator-dependent technique for peripheral endothelial function assessment 10, 12, 14, 15, 18 that noninvasively reflects coronary endothelial function. 12, 16 FMD attenuates markedly with advancing age. In contrast, digital vascular function (RHI) well reflects metabolic risk factors including obesity, high cholesterol, diabetes, and smoking. 28 Rubinshtein et al demonstrated a significant association between RHI and future cardiovascular events during a 7-year followup period among patients without CAD. 13 In the high-risk 30 We can introduce and evaluate the clinical efficacy of new approaches to achieve optimal therapies with improving endothelial function. RH-PAT reflects changes in flow and digital microvessel dilation. 18 Validation studies have shown that impairment in peripheral finger endothelial function measured with RH-PAT is correlated with coronary microvascular function. 16 In this study, we clarified the new aspect that peripheral microvascular endothelial function as assessed by RHI can predict cardiovascular events in conductance vessels. The fact that endothelial dysfunction is a systemic condition may explain why peripheral microvascular endothelial function correlates with endothelial function in the coronary arteries (conductance vessels). 13, [31] [32] [33] Taken together, we suggest that peripheral microvascular endothelial dysfunction could associate with the burden of cardiovascular risk and could be considered a barometer of the total risk burden (the risk of the risk factors). Endothelial dysfunction, as assessed by RHI, could be modestly explained by clinically available risk factors, 34 which
suggests that the majority of contributing pathogenic factors to endothelial dysfunction have not yet been fully elucidated. The medical community really needs to recognize that a clinical assessment of endothelial function could be an integrated parameter reflecting unknown atherogenic factors, including mental stress, environmental, and genetic background. The RH-PAT technique is less operator-dependent and has good reproducibility. 35 We would potentially introduce the noninvasive endothelial function tests in the future practical medicine. 18 Past studies, including the Framingham study, demonstrated that baseline pulse amplitude was positively related to most cardiovascular risk factors and Ln_RH-PAT ratio was negatively associated with most cardiovascular disease risk factors. 15, 28 Whereas in this study, significant positive relation to baseline pulse amplitude was observed only in age, male sex, body mass index, and systolic blood pressure. Age, male sex, body mass index, total/HDL cholesterol ratio, use of antihypertensive drugs, CAD, and SYNTAXsc were negatively correlated with Ln_RH-PAT ratio. There are several plausible explanations for the discrepancies with prior reports. The high-aged study patients, the small sample size, and the high prevalence of cardiovascular risk factors (hypertension, dyslipidemia, diabetes, and male) and CAD could cause these discrepancies. These high-risk profiles could also be one reason for the lower Ln_RH-PAT ratio in this study compared to previous studies. 15, 28 The present trial was limited because it was a 2-center design with a small patient population. Further multicenter studies will be required to confirm our results in a larger patient population.
In conclusion, advanced endothelial dysfunction was significantly associated with adverse cardiovascular events in high-risk patients. Patients with advanced endothelial dysfunction as identified by the lower RHI might have vulnerable vasculature and endothelium. Clinical evaluation of endothelial function with RHI could provide useful and complementary prognostic information to improve risk assessment for the near-future cardiovascular events in high-risk patients.
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